Protein Sequencing Market is poised to register a CAGR of 3.3% during the forecast period 2022 to 2028.

The increasing focus from pharmaceutical biotechnology companies towards target-based drug development is expanding the market growth. Advancements in analytical techniques and clinical mass spectrometry are also stimulating market growth. Besides, increasing financial support from public and private organizations for proteomics coupled with technological evolution for the identification of isobaric remnants in protein sequences are positively influencing the market as well.
The protein sequencing market is bifurcated into product & service, technology, application, end-user, and region. In terms of product & service, protein sequencing services are expected to be the front runner of the market. An increasing number of sequencing procedures alongside technological advancements remains the key factor driving the demand for protein sequencing products. Reagents and consumables are also expected to show notable growth owing to the rise in the number of sequencing procedures and advancements in protein sequencing technology.
Based on technology, mass spectrometry is expected to witness high growth owing to its benefits such as identification of modified proteins and cost-efficiency. Prominent players aiming towards the launch of technologically advanced spectrometry instruments are expanding the protein sequencing market size significantly. 
In terms of application, biotherapeutics is expected to control the market growth owing to rising antibiotic resistance of microbes and increasing demand for targeted drug therapy. Technological advancements alongside the benefits of protein sequencing-based methods for drug development processes are positively influencing the market as well.

Academic institutes and research centers segment are expected to control the growth of the market. Academic institutes and research centres receive hefty funding from public and private organizations for proteomic research. They provide various protein sequencing services such as Edman degradation and mass spectrometry. It also overcomes the problem of budget constraints and a lack of infrastructure. Owing to these features there has been a soaring growth of academic institutes and research centres thus propelling the market.

Based on the region, North America is the global leader of the market. Increasing expenditure and research of major biotechnology and pharmaceutical companies is driving the market growth in the region. The rising focus towards structure-based drug design alongside an increase in proteomic research is boosting the presence of the market in the region. The development of protein sequencing data analysis solutions is stimulating the growth of the market in the region.

Major players of the market are: 
Agilent Technologies, Inc., Bioinformatics Solutions, Charles River Laboratories, Proteome Factory, Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters.

Market Segmentation: 

By Product and Service
• Sample Preparation Products & Services
• Protein Sequencing Products
    o Reagents & Consumables
    o Instruments
         • Mass Spectrometry Instruments
         • Edman Degradation Sequencers
    o Analysis Products/Software
• Protein Sequencing Services

By Technology
• Edman Degradation
• Mass Spectrometry

By Application
• Biotherapeutics
• Genetic Engineering
• Other Applications

By End User
• Academic Institutes & Research Centers
• Pharmaceutical & Biotechnology Companies
• Other End Users

By Region
• North America
• Asia Pacific
• Latin America
• Rest of the World

Competitive Landscape: 

  • Thermo Fisher Scientific is one of the biggest players in the market and through product innovation and technological innovation bolstered the market. The company launched mass spectrometry platforms like Orbitrap, Fusion Lumos Tribrid Mass Spectrum. The product launches helped the company's growth in consumables as well
  • Shimadzu in 2018, launched Quadrupole time-of-flight (Q-TOF) LCMS-9030 System
  • SGS S.A acquired Vanguard Sciences Inc in 2018. The acquisition helped SGS S.A to enhance its protein sequencing offering for the safety of food
  • Charles River Laboratories in a bid to support the development and characterization of biosimilars and biologics opened its Biologics Testing Facility Solutions facility in Pennsylvania, US

FutureWise Key Takeaways:

  • Growth Prospects
  • SWOT Analysis
  • Key Trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the protein sequencing market by product & service, by technology, by application, by end-user and by region 
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • Evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics